MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on November 11, 2015. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 11, 2015. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 11, 2015. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
Plasmapheresis in fulminating crescentic nephritis.
Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis.
Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group.
Lupus nephritis: MAINTAINing perspective in lupus nephritis trials.
Plasmapheresis in systemic lupus erythematosus.
Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis.
Lupus nephritis: Multitarget induction therapy for LN.
Letter: Lupus nephritis.
Mesangial lupus nephritis.
Chapter 12: Lupus nephritis.
Current treatment recommendations for lupus nephritis.
Tubulointerstitial lupus nephritis.
Immunopathology of lupus nephritis.
Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study.
[Lupus nephritis: up-to-date].
Lupus nephritis management guidelines compared.
The Pathogenesis of Lupus Nephritis.
Pediatric lupus nephritis: Management update.
Antiphospholipid Antibodies in Lupus Nephritis.
The management of lupus nephritis.
Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Renal-Limited "Lupus-Like" Nephritis: How Much of a Lupus?
Rituximab in systemic lupus erythematosus and lupus nephritis.
Plasmapheresis for lupus nephritis.
The New England Journal of Medicine Downloaded from nejm.org on November 11, 2015. For personal use only. No other uses without permission. Copyright...
546KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
Plasmapheresis in fulminating crescentic nephritis.
Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis.
Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group.
Lupus nephritis: MAINTAINing perspective in lupus nephritis trials.
Plasmapheresis in systemic lupus erythematosus.
Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis.
Lupus nephritis: Multitarget induction therapy for LN.
Letter: Lupus nephritis.
Mesangial lupus nephritis.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms